Ignite Creation Date:
2025-12-25 @ 12:31 AM
Ignite Modification Date:
2026-01-10 @ 2:30 PM
Study NCT ID:
NCT00849667
Status:
TERMINATED
Last Update Posted:
2022-12-30
First Post:
2009-02-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse
Sponsor:
Morphotek
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MORAb003-004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |